1. A European, Observational, Prospective Trial of Trabectedin Plus Pegylated Liposomal Doxorubicin in Patients with Platinum‐Sensitive Ovarian Cancer. (3rd January 2021) Authors: Pignata, Sandro; Scambia, Giovanni; Villanucci, Alessandro; Naglieri, Emanuele; Ibarbia, Mikel Arruti; Brusa, Federica; Bourgeois, Hugues; Sorio, Roberto; Casado, Antonio; Reichert, Dietmar; Dopchie, Catherine; De Rivas, Beatriz; de Sande, Luis Miguel Journal: Oncologist Issue: Volume 26:Number 4(2021) Page Start: e658 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A European, Observational, Prospective Trial of Trabectedin Plus Pegylated Liposomal Doxorubicin in Patients with Platinum‐Sensitive Ovarian Cancer. (3rd January 2021) Authors: Pignata, Sandro; Scambia, Giovanni; Villanucci, Alessandro; Naglieri, Emanuele; Ibarbia, Mikel Arruti; Brusa, Federica; Bourgeois, Hugues; Sorio, Roberto; Casado, Antonio; Reichert, Dietmar; Dopchie, Catherine; De Rivas, Beatriz; Sande, Luis Miguel Journal: Oncologist Issue: Volume 26:Number 4(2021) Page Start: e658 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A Pragmatic Study Evaluating NEPA Versus Aprepitant for Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Moderately Emetogenic Chemotherapy. (22nd July 2021) Authors: Zelek, Laurent; Debourdeau, Philippe; Bourgeois, Hugues; Wagner, Jean Philippe; Brocard, Fabien; Lefeuvre-Plesse, Claudia; Chauffert, Bruno; Leheurteur, Marianne; Bachet, Jean-Baptiste; Simon, Hélène; Mayeur, Didier; Scotté, Florian Journal: Oncologist Issue: Volume 26:Number 10(2021) Page Start: e1870 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A Pragmatic Study Evaluating NEPA Versus Aprepitant for Prevention of Chemotherapy‐Induced Nausea and Vomiting in Patients Receiving Moderately Emetogenic Chemotherapy. (22nd July 2021) Authors: Zelek, Laurent; Debourdeau, Philippe; Bourgeois, Hugues; Wagner, Jean Philippe; Brocard, Fabien; Lefeuvre‐Plesse, Claudia; Chauffert, Bruno; Leheurteur, Marianne; Bachet, Jean‐Baptiste; Simon, Hélène; Mayeur, Didier; Scotté, Florian Journal: Oncologist Issue: Volume 26:Number 10(2021) Page Start: e1870 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Avelumab in patients with previously treated metastatic melanoma: phase 1b results from the JAVELIN Solid Tumor trial. Issue 1 (16th January 2019) Authors: Keilholz, Ulrich; Mehnert, Janice M.; Bauer, Sebastian; Bourgeois, Hugues; Patel, Manish R.; Gravenor, Donald; Nemunaitis, John J.; Taylor, Matthew H.; Wyrwicz, Lucjan; Lee, Keun-Wook; Kasturi, Vijay; Chin, Kevin; von Heydebreck, Anja; Gulley, James L. Journal: Journal for immunotherapy of cancer Issue: Volume 7:Issue 1(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Clinical effectiveness of olaparib monotherapy in germline BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: phase IIIb LUCY interim analysis. (July 2021) Authors: Gelmon, Karen A.; Fasching, Peter A.; Couch, Fergus J.; Balmaña, Judith; Delaloge, Suzette; Labidi-Galy, Intidhar; Bennett, James; McCutcheon, Susan; Walker, Graham; O'Shaughnessy, Joyce; Timcheva, Constanta; Tomova, Antoaneta; Eisen, Andrea; Gelmon, Karen; Lemieux, Julie; Bazan, Fernando; Bourge... Journal: European journal of cancer Issue: Volume 152(2021) Page Start: 68 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Erratum to "First-line ribociclib plus letrozole for postmenopausal women with HR+, HER2- ABC: MONALEESA-2 safety results" [Breast 36 (Suppl. 1) (November 2017) S44–S45]. (August 2018) Authors: Janni, Wolfgang; Chan, Arlene; Nusch, Arnd; Alba, Emilio; Bachelot, Thomas; Gil-Gil, Miguel; Kattan, Joseph; Bourgeois, Hugues; El Karak, Fadi; Sutradhar, Santosh; Miller, Michelle; Chandiwana, David; Conte, Pierfranco Journal: Breast Issue: Volume 40(2018) Page Start: 53 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Expected Benefits of Topotecan Combined With Lapatinib in Recurrent Ovarian Cancer According to Biological Profile: A Phase 2 Trial. Issue 9 (1st November 2012) Authors: Lheureux, Stéphanie; Krieger, Sophie; Weber, Béatrice; Pautier, Patricia; Fabbro, Michel; Selle, Frédéric; Bourgeois, Hugues; Petit, Thierry; Lortholary, Alain; Plantade, Anne; Briand, Mélanie; Leconte, Alexandra; Richard, Nicolas; Vilquin, Paul; Clarisse, Bénédicte; Blanc-Fournier, Cécile; Joly,... Journal: International journal of gynecological cancer Issue: Volume 22:Issue 9(2012) Page Start: 1483 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. First-Line Ribociclib Plus Letrozole for Postmenopausal Women with HR+, HER2-ABC: Manaleesa-2 Safety Results. (November 2017) Authors: Janni, Wolfgang; Chan, Arlene; Nusch, Arnd; Alba, Emilio; Bachelot, Thomas; Gil-Gil, Miguel; Kattan, Joseph; Bourgeois, Hugues; El Karak, Fadi; Sutradhar, Santosh; Miller, Michelle; Chandiwana, David; Conte, Pierfranco Journal: Breast Issue: Volume 36(2017)Supplement 1 Page Start: S44 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Quality of advanced ovarian cancer surgery: A French assessment of ESGO quality indicators. Issue 2 (February 2021) Authors: Gac, Marie-Mélanie; Loaec, Cécile; Silve, Johanna; Vaucel, Edouard; Augereau, Paule; Wernert, Romuald; Bourgin, Charlotte; Aireau, Xavier; Lortholary, Alain; Descamps, Philippe; Priou, Frank; Deblaye, Pascaline; Bourgeois, Hugues; Delecroix, Valérie; Empereur, Fabienne; Campion, Loïc; Classe, Jea... Journal: European journal of surgical oncology Issue: Volume 47:Issue 2(2021) Page Start: 360 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗